去泛素化酶OTUD6B调控VHL突变体稳定性抑制肾癌细胞迁移的作用和机制研究

去泛素化酶OTUD6B调控VHL突变体稳定性抑制肾癌细胞迁移的作用和机制研究摘要：

近年来，肾癌的罹患率逐年增加，使得该疾病的研究备受关注。本研究利用体外和体内实验探究了OTUD6B的去泛素化酶功能对VHL突变体稳定性和肾癌细胞迁移的影响。结果表明，OTUD6B的过表达可以抑制VHL的降解及降解途径所需的泛素化作用，使得其蛋白稳定性增强。此外，OTUD6B还可以抑制肾癌细胞的迁移和侵袭，并且此作用与VHL蛋白的稳定性密切相关。机制研究发现，OTUD6B通过阻止VHL蛋白的泛素化与降解，降低了HIF-1α的稳定性及其下游基因的表达，从而抑制了肾癌细胞的迁移。综上所述，本研究揭示了OTUD6B调控VHL稳定性抑制肾癌细胞迁移的作用和机制，为肾癌的治疗研究提供了新的思路。

关键词：OTUD6B；VHL蛋白；去泛素化酶；肾癌；HIF-1α；肿瘤迁移

Abstract:

Inrecentyears,theincidenceofkidneycancerhasincreasedyearbyyear,makingthestudyofthisdiseasehighlyvalued.Inthisstudy,theeffectsofOTUD6B'sdeubiquitinationfunctiononthestabilityofVHLmutantandthemigrationofrenalcancercellswereexploredthroughinvitroandinvivoexperiments.TheresultsshowedthattheoverexpressionofOTUD6BcaninhibitthedegradationofVHLandtheubiquitinationrequiredforthedegradationpathway,makingitsproteinstabilityincrease.Inaddition,OTUD6Bcanalsoinhibitthemigrationandinvasionofrenalcancercells,andthiseffectiscloselyrelatedtothestabilityofVHLprotein.MechanismstudiesfoundthatOTUD6BreducesthestabilityofHIF-1αanditsdownstreamgenesbypreventingtheubiquitinationanddegradationofVHLprotein,therebyinhibitingthemigrationofrenalcancercells.Insummary,thisstudyrevealstheroleandmechanismofOTUD6BinregulatingVHLstabilitytoinhibitthemigrationofrenalcancercells,providinganewapproachforthetreatmentofkidneycancer.

Keywords:OTUD6B;VHLprotein;deubiquitinase;renalcancer;HIF-1α;tumormigrationKidneycancerisacommonmalignanttumoraffectingmillionsofpeopleworldwide.Inrecentyears,studieshavefocusedonthemolecularmechanismunderlyingthedevelopmentandprogressionofthiscancer.Oneofthekeyfactorsintheprogressionofrenalcanceristhehypoxia-induciblefactor1alpha(HIF-1α),whichpromotesangiogenesis,cellproliferation,andresistancetochemotherapy.Therefore,targetingHIF-1αisapromisingtherapeuticstrategyforrenalcancer.

PreviousstudieshaveshownthatthevonHippel-Lindauprotein(VHL)playsacriticalroleintheregulationofHIF-1αstabilitybypromotingitsubiquitinationanddegradation.VHLfunctionsasasubstratereceptorforthecullin-RINGE3ubiquitinligasecomplex,whichtargetsHIF-1αforproteasomaldegradationundernormoxicconditions.However,inrenalcancercells,VHLisoftenmutatedorinactivated,leadingtotheaccumulationofHIF-1αandthepromotionoftumormigration.

RecentresearchhasrevealedthatOTUD6B,amemberoftheovariantumor(OTU)domain-containingdeubiquitinasefamily,caninhibitthemigrationofrenalcancercellsbyregulatingVHLstability.OTUD6BactsasadeubiquitinaseforVHL,preventingitsdegradationandpromotingitsstability.This,inturn,promotestheubiquitinationanddegradationofHIF-1α,leadingtothesuppressionoftumormigration.

Inconclusion,thisstudyhasdemonstratedthecriticalroleofOTUD6BinregulatingVHLstabilityandinhibitingthemigrationofrenalcancercellsthroughthedegradationofHIF-1α.ThesefindingsprovideanoveltherapeuticstrategyforthetreatmentofkidneycancerandhighlightthepotentialoftargetingOTUD6BandVHLinthedevelopmentofnewcancertherapiesKidneycancerisasignificanthealthproblemworldwideandaleadingcauseofcancer-relateddeath.Despiteadvancesindiagnosisandtreatment,theprognosisforpatientswithmetastatickidneycancerremainspoor.Therefore,theidentificationofnoveltherapeutictargetsiscriticalfordevelopingnewtreatmentsforthisdisease.

Thestudypresentedherehasidentifiedanoveltargetforthetreatmentofkidneycancer,thedeubiquitinaseOTUD6B.TheresearchersfoundthatOTUD6BplaysacriticalroleinregulatingVHLstabilityandinhibitingthemigrationofrenalcancercellsthroughthedegradationofHIF-1α.ThesefindingshighlightthepotentialoftargetingOTUD6BandVHLinthedevelopmentofnewcancertherapies.

Oneofthestrengthsofthisstudywastheuseofmultipletechniques,includingbioinformaticsanalysis,invitroandinvivoexperiments,toinvestigatetheroleofOTUD6Binkidneycancer.Thefindingsofthisstudyprovideamorecomprehensiveunderstandingofthemolecularmechanismsthatunderliethedevelopmentandprogressionofkidneycancer.

However,therearesomelimitationstothestudythatshouldbeaddressedinfutureresearch.Forexample,thestudymainlyfocusedontheroleofOTUD6Binrenalcancercellmigrationanddidnotinvestigateitseffectsonothercellularprocesses,suchasproliferationandapoptosis.Additionally,thestudywasconductedinvitroandinamousemodel,andthus,theresultsmaynotnecessarilyreflectthebehaviorofhumantumors.Therefore,futurestudiesshouldextendtheinvestigationtohumantumorstovalidatetheclinicalrelevanceofthefindings.

Inconclusion,thestudyhasidentifiedanimportantroleforOTUD6BinregulatingVHLstabilityandinhibitingthemigrationofrenalcancercellsthroughthedegradationofHIF-1α.Thesefindingsprovideapotentialtherapeutictargetforkidneycancerandmayhavebroadimplicationsforthetreatmentofothertypesofcancer.FuturestudieswillberequiredtofurtherinvestigatetheclinicalrelevanceofthesefindingsandthepotentialoftargetingOTUD6BandVHLinthedevelopmentofnewcancertherapiesInadditiontothepotentialtherapeuticimplicationsforkidneycancer,thediscoveryoftherelationshipbetweenOTUD6BandVHLmayhavebroaderimplicationsfortheunderstandingandtreatmentofothertypesofcancer.VHLmutationsarealsoimplicatedincertaintypesofpancreaticandadrenalglandtumors.Furthermore,otherproteinsthataresimilartoVHL,referredtoasE3ubiquitinligases,havealsobeenshowntoplayaroleincancerdevelopmentandprogression.

UnderstandingtheprecisemechanismsbywhichOTUD6BregulatesVHLstabilityandHIF-1αdegradationmayprovideimportantinsightsintotheregulationofotherE3ubiquitinligasesandtheirsubstrates.Morebroadly,thesefindingsunderscoretheimportanceofubiquitin-mediatedproteindegradationincancerdevelopmentandprogression.Theubiquitinsystemisacomplexnetworkofproteinsandenzymesthatworktogethertotagproteinsfordegradationandrecycletheiraminoacids.Dysregulationoftheubiquitinsystemhasbeenimplicatedinawiderangeofdiseases,includingcancer,neurodegenerativedisorders,andautoimmunediseases.

Insummary,thediscoveryoftheroleofOTUD6BinregulatingVHLstabilityandinhibitingthemigrationofrenalcancercellsthroughthedegradationofHIF-1αprovidesapotentialnewtherapeutictargetforkidneycancerandunderscorestheimpor